Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sage Therapeutics, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 38.95||$ 89.035|
|Low||$ 36.245||$ 26.2801|
The current last sale of $37.92 is 44.29% Higher thanthe 52 week low.
ETFs with SAGE as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|0%||BioShares Biotechnology Clinical Trials Fund (BBC)||-10.73 (-34.35%)|
Company Description (as filed with the SEC)
We are a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening central nervous system, or CNS, disorders, where there are inadequate or no approved existing therapies. We are targeting CNS indications where patient populations are easily identified, clinical endpoints are well-defined, and development pathways are feasible. Our lead product candidate is SAGE-547, a proprietary intravenous formulation of allopregnanolone, a naturally occurring neurosteroid that acts as a synaptic and extrasynaptic modulator of the GABAA receptor. GABA is the major inhibitory neurotransmitter in the CNS, and mediates downstream neurologic and bodily function via activation of GABAA receptors. ... More ...
Where does SAGE fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-3.4|
|Quarterly EPS Est:||-0.97|